Abstract
Biologist Matt Kaeberlein has never quite managed to blend into the ranks. He was first to graduate in his class at the Massachusetts Institute of Technology, completing his Ph.D. in a mere 4 years and 3 months. During that time, he helped pinpoint the central gene that controls aging in brewer's yeast. Now, at the age of 31, he is vice president, as well as a co-founder, of biotech start-up Longenity.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
